Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Drucker

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Neuro-Oncology|May 10, 2020
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20CJeanette E Eckel-Passow, Kristen L Drucker, Thomas M Kollmeyer, et al.
Neuro-Oncology|January 10, 2019
Using germline variants to estimate glioma and subtype risksJeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, et al.
Brain Pathology (Zurich, Switzerland)|February 6, 2026
Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalitiesJorge A Trejo-Lopez, Cinthya Zepeda Mendoza, Thomas M Kollmeyer, et al.
Science (New York, N.Y.)|October 6, 2022
A noncoding single-nucleotide polymorphism at 8q24 drives <i>IDH1</i>-mutant glioma formationConnor Yanchus, Kristen L Drucker, Thomas M Kollmeyer, et al.
Pageof 6